Re: Why now?
in response to
by
posted on
Dec 31, 2020 08:38AM
Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials
If it was valued at zero, it suggests no one ever got around to valuing it. Why now? Perhaps in response to another customer's enquiry. If my brokerage valued it at zero, I'd keep on them until they fixed it. If you check the daily value and it changes, it may be ZHCLF (OTC) converted to Canadian dollars (75¢ CAD looks in the ballpark). If it doesn't change, it's likely just their attempt to value it. One brokerage has had it at $1.00 US for a while now.